You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 26 No. 5, May 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  BRIEF COMMUNICATION
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Febrile Penicillamine Eruption

CDR G. Thomas Strickland, MC, USN

Arch Neurol. 1972;26(5):474.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SEVEN of 21 Chinese patients with Wilson's disease had an acute febrile reaction five to ten days after starting penicillamine therapy. This included a maculopapular (morbilliform) rash, fever, lymphadenopathy, increase in size of the spleen and liver, edema, weight gain, microscopic hematuria and minimal proteinuria, coryza, inflamed throat, and positive tourniquet tests. A similar reaction occurred in a normal volunteer subject. Petechiae and decreases in white blood cell and platelet counts occurred in patients treated the longest after onset of symptoms. Eosinophilia was minimal. Skin biopsies from three patients demonstrated chronic inflammatory cells distributed particularly around small blood vessels, and were compatible with a drug reaction.

Abnormal findings cleared three to five days following discontinuation of penicillamine. In three patients symptoms recurred when penicillamine was reinstituted at the same dosage. Desensitization was accomplished by starting at low doses and increasing at weekly intervals. On every occasion the program was . . . [Full Text PDF of this Article]


Author Affiliations

Taipei, Taiwan

From the Department of Clinical Investigation, US Naval Medical Research Unit No. 2, Taipei, Taiwan. Dr. Strickland is now with the London School of Hygiene and Tropical Medicine, London.


Footnotes

Accepted for publication Nov 22, 1971.

Reprint requests to Publications Editor, NAMRU-2, Box 14, APO San Francisco 96263.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.